TRJNF (Trajan Group Holdings) ROCE %: 0.33% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TRJNF Trajan Group Holdings Ltd TRJNF
38 GF Score
Price $0.40
GF Value $1.53
! 2 Warning Signs
View Full Analysis

What is Trajan Group Holdings ROCE %?

Trajan Group Holdings TRJNF 38 ROCE % is 0.33% as of Dec. 2025. GuruFocus rates TRJNF with a GF Score™ of 38/100 and a GF Value™ of $1.53. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Trajan Group Holdings's annualized ROCE % for the quarter that ended in Dec. 2025 was 0.33%.

Trajan Group Holdings  (OTCPK:TRJNF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Trajan Group Holdings ROCE % Related Terms

Trajan Group Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for Trajan Group Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trajan Group Holdings ROCE % Chart

Trajan Group Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
3.26 2.97 5.46 -17.60 1.28

Trajan Group Holdings Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1.43 -34.95 -1.34 3.68 0.33
TRJNF
38GF Score
Trajan Group Holdings Ltd TRJNF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trajan Group Holdings ROCE % Calculation

Trajan Group Holdings's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=1.169/( ( (124.833 - 47.908) + (127.365 - 22.288) )/ 2 )
=1.169/( (76.925+105.077)/ 2 )
=1.169/91.001
=1.28 %

Trajan Group Holdings's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=0.348/( ( (127.365 - 22.288) + (127.789 - 19.918) )/ 2 )
=0.348/( ( 105.077 + 107.871 )/ 2 )
=0.348/106.474
=0.33 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.33% mean?
Trajan Group Holdings (TRJNF) has a ROCE % of 0.33% as of Dec. 2025.
Is Trajan Group Holdings' ROCE % too high?
Trajan Group Holdings' current ROCE % is 0.33%. The Medical Devices & Instruments industry median ROCE % is 2.30. Trajan Group Holdings' value of 0.33% is 85.6% below this industry median. Overall, Trajan Group Holdings has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Trajan Group Holdings' ROCE % compare to ISRG and BDX?
Trajan Group Holdings' ROCE % of 0.33% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.30. Trajan Group Holdings' value of 0.33% is 85.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.30, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trajan Group Holdings's current ROCE % of 0.33% is 85.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trajan Group Holdings's current ROCE % is 0.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trajan Group Holdings stock overvalued right now?
Trajan Group Holdings (TRJNF) has a current ROCE % of 0.33%. The stock's GF Value™ is $1.53, compared to a current price of $0.40 — trading 73.9% below its estimated fair value. The current ROCE % is 0.33% and 85.6% below the Medical Devices & Instruments industry median of 2.30. Trajan Group Holdings' overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Trajan Group Holdings (TRJNF), the current ROCE % is 0.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trajan Group Holdings (TRJNF) Overvalued in 2026?

Based on GuruFocus' analysis, Trajan Group Holdings stock appears to be undervalued. The current stock price of $0.40 is trading 73.9% below its estimated GF Value™ of $1.53.

Key valuation signals for TRJNF:

  • ROCE %: 0.33%
  • GF Value™: $1.53 vs. price of $0.40 (73.9% below fair value)
  • GF Score™: 38/100 with 2 warning signs
  • Industry Position: 85.6% below the Medical Devices & Instruments median

No single metric tells the full story. See the TRJNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Trajan Group Holdings Business Description

Other Exchanges TRJ:Australia
Address 7 Argent Place, Ringwood, VIC, AUS, 3134
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental samples. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and consumables, which include parts, supplies, components, and consumable products worldwide. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).
38GF Score

Get the complete analysis for TRJNF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$1.53
GF Value